Mill Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$611K Hold
6,761
0.05% 91
2025
Q4
$608K Hold
6,761
0.04% 90
2025
Q3
$666K Hold
6,761
0.05% 87
2025
Q2
$617K Hold
6,761
0.05% 87
2025
Q1
$765K Hold
6,761
0.06% 84
2024
Q4
$714K Hold
6,761
0.06% 84
2024
Q3
$730K Hold
6,761
0.06% 86
2024
Q2
$734K Hold
6,761
0.06% 85
2024
Q1
$892K Hold
6,761
0.07% 82
2023
Q4
$823K Hold
6,761
0.07% 84
2023
Q3
$759K Hold
6,761
0.07% 84
2023
Q2
$984K Buy
6,761
+463
+7% +$62.9K 0.09% 76
2023
Q1
$814K Sell
6,298
-463
-7% -$58.1K 0.08% 84
2022
Q4
$862K Hold
6,761
0.09% 79
2022
Q3
$707K Sell
6,761
-10
-0.1% -$1.1K 0.08% 80
2022
Q2
$711K Hold
6,771
0.08% 81
2022
Q1
$866K Sell
6,771
-203
-3% -$24.5K 0.08% 86
2021
Q4
$860K Buy
+6,974
New +$913K 0.09% 73

Other funds holding ZBH

Mill Capital Management's ZBH Position: Q1 2026 in Review

Mill Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 6,761 shares worth $611K. The position accounts for 0.05% of the portfolio, ranked #91.

Mill Capital Management first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $984K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Mill Capital Management held 6,761 shares of Zimmer Biomet worth $611K as of Q1 2026.
  • Mill Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.05% of Mill Capital Management's portfolio in Q1 2026, its #91 holding.
  • Mill Capital Management first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
  • Mill Capital Management's Zimmer Biomet position peaked at $984K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.